Bronte Capital Management Pty Ltd. - Q4 2020 holdings

$633 Million is the total value of Bronte Capital Management Pty Ltd.'s 15 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 15.4% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.

 Value Shares↓ Weighting
BRKB SellBERKSHIRE HATHAWAY INC DELcl b new$113,951,000
+14.0%
491,444
-0.8%
18.00%
+2.3%
HLF  HERBALIFE NUTRITION LTD$99,043,000
+6.4%
2,061,2450.0%15.65%
-4.5%
IBKR SellINTERACTIVE BROKERS GROUP$78,541,000
+26.5%
1,289,241
-1.2%
12.41%
+13.5%
V SellVISA INC$68,340,000
-5.5%
312,438
-21.5%
10.80%
-15.2%
IWM NewISHARES TRcall$59,246,00030,000
+100.0%
9.36%
SPY  SPDR S&P 500 ETF TRcall$56,341,000
+11.7%
15,0000.0%8.90%
+0.2%
CTVA  CORTEVA NC$32,359,000
+17.4%
835,7140.0%5.11%
+5.3%
GOOG  ALPHABET INCcap stk cl c$23,488,0000.0%14,4900.0%3.71%
-10.3%
GOOGL SellALPHABET INCcap stk cl a$22,049,000
-71.1%
12,586
-73.3%
3.48%
-74.1%
BK SellBANK NEW YORK MELLON CORP$20,385,000
+21.1%
480,315
-2.0%
3.22%
+8.6%
NEM SellNEWMONT CORP$19,870,000
-17.0%
331,769
-12.9%
3.14%
-25.5%
STT SellSTATE STR CORP$19,180,000
+20.2%
263,537
-2.8%
3.03%
+7.8%
REGN NewREGENERON PHARMACEUTICALS$9,205,00019,053
+100.0%
1.45%
GHC BuyGRAHAM HLDGS CO$7,248,000
+87.4%
13,588
+33.6%
1.14%
+68.1%
MACK  MERRIMACK PHARMACEUTICALS IN$3,662,000
+78.5%
531,5100.0%0.58%
+60.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL20Q3 202322.6%
ALPHABET INC-CL A20Q3 202314.4%
HERBALIFE NUTRITION LTD20Q3 202322.0%
INTERACTIVE BROKERS GROUP20Q3 202312.4%
ALPHABET INC-CL C20Q3 20235.7%
VISA INC-CLASS A SHARES19Q2 202316.6%
CORTEVA NC17Q3 20236.2%
GRAHAM HOLDINGS CO-CLASS B13Q3 20232.1%
REGENERON PHARMACEUTICALS12Q3 202313.0%
STATE STREET CORP12Q2 20233.0%

View Bronte Capital Management Pty Ltd.'s complete holdings history.

Latest filings
TypeFiled
SCHEDULE 13G2024-02-13
13F-HR2024-02-07
13F-HR2023-11-06
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-03
13F-HR/A2022-08-08
13F-HR2022-08-08
13F-HR2022-05-13

View Bronte Capital Management Pty Ltd.'s complete filings history.

Compare quarters

Export Bronte Capital Management Pty Ltd.'s holdings